Corporate Compliance Partners Corporate Compliance Partners
 Sarbanes-Oxley News & Developments
Sarbanes-Oxley Bill We Can Help You The Compliance Network About Us

Sarbanes-Oxley News & Developments

Investors Must Prove Loss in Fraud Suits

Investors accusing a company of securities fraud must make a direct connection between the fraud and a subsequent decline in the company share price.

> > The Supreme Court ruling, which overturned an opinion of the U.S. Court of Appeals for the Ninth Circuit, stemmed from a lawsuit against Dura Pharmaceuticals. The suit sought damages on behalf of investors who bought Dura shares between April 15, 1997, and February 24, 1998. The share price of the company declined sharply in 1998 after earnings came in lower than expected, then again after the Food and Drug Administration failed to approve a new Dura asthma inhaler for sale.
Source: CFO


Published:2005-04-20
Subscribe to the CCP Report, our free weekly newsletter about SOX! Your Email Address:

 More Resources

More News

The View from the Other Side
Can IT live up to the expectations for governance, compliance, and revenue generation of a CFO?

Capital Markets Report Urges 404 Fixes
A panel says changes in the way Sarbanes-Oxley has been applied will improve the competitiveness of the U.S. capital markets.

Wal-Mart Whistleblower Drops Lawsuit
Former executive still has a whistleblower case pending before the Labor Department.

All News

Sarbanes-Oxley Act SEC Rules Exchange Rules



The View from the Other Side
Can IT live up to the expectations for governance, compliance, and revenue generation of a CFO?


Sarbanes-Oxley Bill | Are You Compliant? | We Can Help You | About Us
Home | Site Map | Contact Us | Privacy Policy

For more information, please contact us at ccp@answernet.com
AnswerNet © - All rights reserved.